Submit your request and our team will follow up within one business day
In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
Regulatory frameworks vary see our country-specific legal guides in the /learn section for ANVISA (Brazil), AMG (Germany), MHRA (UK), HPRA (Ireland), and AIFA (Italy) details
Biomedicines , 11(5), 1340
The guarantee allows users to trial the product with limited financial risk, understanding they can obtain refunds if results do not meet expectations